![Jan Birger Fredrik Toernell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jan Birger Fredrik Toernell
Directeur/Bestuurslid bij ABLIVA AB
Actieve functies van Jan Birger Fredrik Toernell
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ABLIVA AB | Directeur/Bestuurslid | 27-04-2017 | - |
Independent Dir/Board Member | 27-04-2017 | - | |
University of Gothenburg | Corporate Officer/Principal | - | - |
Sahlgrenska University | Corporate Officer/Principal | - | - |
Innoext AB
![]() Innoext AB Miscellaneous Commercial ServicesCommercial Services Innoext AB provides management consulting services. The private company is based in Västra Frölunda, Sweden. Jan Birger Fredrik Toernell has been the CEO of the Swedish company since 2011. | Directeur/Bestuurslid | 01-07-2011 | - |
Algemeen Directeur | 01-07-2011 | - | |
Lidds Pharma AB | Corporate Officer/Principal | - | - |
Aqilion AB
![]() Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Private Equity Investor | 29-05-2012 | - |
Glactone Pharma AB
![]() Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Voorzitter | 01-07-2012 | - |
Stayble AB | Directeur/Bestuurslid | - | - |
Diaprost AB
![]() Diaprost AB Miscellaneous Commercial ServicesCommercial Services Diaprost AB is a private pharmaceutical research and development company based in Lund, Sweden. Diaprost collaborates with leading international experts in the fields of molecular medicine, biotechnology, immunology, radiology, radiation physics, laboratory medicine, and oncology. The Swedish company has an agreement with a top 10 pharma company for its first antibody H11B6 targeting the HK2 antigen, which is in early clinical development. The remaining Diaprost pipeline consists of 5A10, which targets free-PSA antigen for both diagnostic and therapeutic applications. The company was founded in 2005 with the aim of leveraging the transformative success of the PSA assay for detection of prostate cancer as a personalized theranostic platform. Johan Drott has been the CEO of the company since 2015. | Directeur/Bestuurslid | 01-06-2012 | - |
░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░░ | - | - | |
░░░░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░ | - | - |
Loopbaan van Jan Birger Fredrik Toernell
Eerdere bekende functies van Jan Birger Fredrik Toernell
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | - | - |
Opleiding van Jan Birger Fredrik Toernell
University of Gothenburg | Doctorate Degree |
Statistieken
Internationaal
Zweden | 19 |
Verenigd Koninkrijk | 2 |
Operationeel
Director/Board Member | 6 |
Chairman | 5 |
Corporate Officer/Principal | 5 |
Sectoraal
Health Technology | 9 |
Commercial Services | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
LIDDS AB | Health Technology |
STAYBLE THERAPEUTICS AB | Health Technology |
ASTRAZENECA PLC | Health Technology |
ABLIVA AB | Health Technology |
ISOFOL MEDICAL AB | Health Technology |
Bedrijven in privébezit | 12 |
---|---|
Aqilion AB
![]() Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Finance |
Glactone Pharma Development AB | |
Innoex AB | |
Diaprost AB
![]() Diaprost AB Miscellaneous Commercial ServicesCommercial Services Diaprost AB is a private pharmaceutical research and development company based in Lund, Sweden. Diaprost collaborates with leading international experts in the fields of molecular medicine, biotechnology, immunology, radiology, radiation physics, laboratory medicine, and oncology. The Swedish company has an agreement with a top 10 pharma company for its first antibody H11B6 targeting the HK2 antigen, which is in early clinical development. The remaining Diaprost pipeline consists of 5A10, which targets free-PSA antigen for both diagnostic and therapeutic applications. The company was founded in 2005 with the aim of leveraging the transformative success of the PSA assay for detection of prostate cancer as a personalized theranostic platform. Johan Drott has been the CEO of the company since 2015. | Commercial Services |
Stayble AB | |
Oncorena AB
![]() Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
Glactone Pharma AB
![]() Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Health Technology |
Oncorena Holding AB
![]() Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
Lidds Pharma AB | |
Innoext AB
![]() Innoext AB Miscellaneous Commercial ServicesCommercial Services Innoext AB provides management consulting services. The private company is based in Västra Frölunda, Sweden. Jan Birger Fredrik Toernell has been the CEO of the Swedish company since 2011. | Commercial Services |
Hammars Bryggeri AB
![]() Hammars Bryggeri AB Beverages: AlcoholicConsumer Non-Durables Hammars Bryggeri AB engages in brewery operations. It produces a wide range of soft drinks, water, and other cider beverages. The company was founded in 1904 and is headquartered in Hammar, Sweden. | Consumer Non-Durables |
Puls AB
![]() Puls AB Environmental ServicesIndustrial Services Puls AB is a Swedish company that specializes in sewage, industrial, and environmental services. Puls is located in Staffanstorp, Sweden and is known as the largest player in va maintenance in southern Sweden. The private company offers on-call assistance for a range of issues, including emergency stops in the drain and remediation after accidents. The company provides services such as sewage cleaning, wastewater flushing, and water blasting to clean tanks, cisterns, sheet metal, boat hulls, and more in an environmentally friendly manner. The company has a team of talented employees who specialize in water and wastewater services for tenant-owner associations, offering maintenance and emergency measures. | Industrial Services |